168 related articles for article (PubMed ID: 6858048)
1. [Immunologic response in patients with melanoma of the skin].
Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
[TBL] [Abstract][Full Text] [Related]
2. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
5. [Skin reactions of delayed hypersensitivity in melanoblastoma].
Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
Bullen AW; Losowsky MS
Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
[TBL] [Abstract][Full Text] [Related]
7. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
8. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
Kalafut F; Cernák A; Pham Manh Hung
Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
[TBL] [Abstract][Full Text] [Related]
9. Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms.
Donawho CK; Muller HK; Bucana CD; Kripke ML
J Immunol; 1996 Jul; 157(2):781-6. PubMed ID: 8752929
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
11. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
12. Immunologic mechanisms in malignant melanoma of the skin.
Cochran AJ
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
[No Abstract] [Full Text] [Related]
13. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous, cellular immunity in malignant melanoma].
Kehrer HC
Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
[No Abstract] [Full Text] [Related]
15. Immune response to melanoma extracts in three melanoma-prone families.
Vandenbark AA; Greene MH; Burger DR; Vetto RM; Reimer RR
J Natl Cancer Inst; 1979 Nov; 63(5):1147-51. PubMed ID: 291746
[TBL] [Abstract][Full Text] [Related]
16. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic diagnosis of malignant neoplasms. I].
Shuster J; Thomson DM; Fuks A; Gold P
Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
[No Abstract] [Full Text] [Related]
18. [Cellular immunity in patients with melanoma].
Gorodinova VV; Kholenshed A; Babakova SV
Vopr Onkol; 1976; 22(12):3-5. PubMed ID: 1020253
[TBL] [Abstract][Full Text] [Related]
19. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
Müller S; Ernst TM
Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
[TBL] [Abstract][Full Text] [Related]
20. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
